|   In the News

Atlas-backed Nimbus hits milestone in agricultural partnership with Monsanto

An Atlas Venture-backed startup that’s developing drugs for various metabolic diseases reached a milestone this week in a partnership that’s totally unrelated to drug discovery — one with the agricultural biotech giant, Monsanto. Read more.

  |   From the Trenches

Company Culture: Continuation On A LifeSciVC Theme

Over the past two weeks in LifeSciVC, I read with great interest and appreciation the blogs of two friends of mine – Bill Marshall and Ankit Mahadevia – as they offered useful perspective on the most powerful tool we have as leaders – company culture.

I am a big believer in working hard at creating the best possible culture for one’s team, so last week, I was deeply honored to see my company recognized as one of the ‘Best Places to Work’ in the state of Pennsylvania.

Read more.

  |   LifeSciVC

Deck The Halls With… Compensation Committees

By Bruce Booth, DPhil, Partner

It’s that time of year again: Santa is preparing his list of naughty and nice biotech management teams, and taking his recommendations to the Compensation Committee. Read more.

  |   From the Trenches

Riding The Biotech Roller Coaster Like A Pro: Some Observations

As startup folks we are great at keeping our heads down and looking ahead; this blog post was a good excuse to take a look back while digesting Thanksgiving leftovers. I’m a bit early for the end of the year analyses; however, in thinking about all of the triumphs and setbacks we’ve encountered in 2014, it occurred to me that much is made of these actual events, but very little is said about how teams handle them.

Read more.

  |   From the Trenches

It’s the People, Stupid: Building and Maintaining a High Performance Corporate Culture

Building a performance based corporate culture is a key aspect of the biotech innovation business.  It can be easy to overlook this facet of company building as one focuses on determining the robustness of the new technology, refining your business model, assessing the intellectual property landscape, rifling through contacts to find great talent and scrambling to attract investors. Read more.